HLB Life Science Co., Ltd. (KOSDAQ:067630)

South Korea · Delayed Price · Currency is KRW

3,280.00

-60.00 (-1.80%)

Oct 29, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Other	6.10B	5.86B	4.99B	5.17B	4.55B
Medicare Division	35.13B	28.02B	30.19B	35.79B	-
Bio Development	358.95M	788.51M	425.99M	312.98M	12.68M
Construction and Engineering	5.35B	1.01B	1.36B	5.89B	11.57B
Internal Sales	-1.18B	-2.90B	-2.39B	-1.62B	-372.94M
Pharmaceutical Distribution	-	-	63.42B	54.06B	37.73B
Total	45.75B	32.77B	97.99B	99.59B	53.49B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	40.61B	31.41B	97.63B	99.48B	53.49B
Foreign Country	5.14B	1.36B	360.71M	107.14M	-
Total	45.75B	32.77B	97.99B	99.59B	53.49B